Skip to main content
Top
Published in: World Journal of Surgery 4/2012

Open Access 01-04-2012

Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort

Authors: Ava Kwong, Connie H. N. Wong, Dacita T. K. Suen, Michael Co, Allison W. Kurian, Dee W. West, James M. Ford

Published in: World Journal of Surgery | Issue 4/2012

Login to get access

Abstract

Background

BRCA1/2 mutation prediction models (BRCAPRO, Myriad II, Couch, Shattuck-Eidens, BOADICEA) are well established in western cohorts to estimate the probability of BRCA1/2 mutations. Results are conflicting in Asian populations. Most studies did not account for gender-specific prediction. We evaluated the performance of these models in a Chinese cohort, including males, before BRCA1/2 mutation testing.

Methods

The five risk models were used to calculate the probability of BRCA mutations in probands with breast and ovarian cancers; 267 were non-BRCA mutation carriers (247 females and 20 males) and 43 were BRCA mutation carriers (38 females and 5 males).

Results

Mean BRCA prediction scores for all models were statistically better for carriers than noncarriers for females but not for males. BRCAPRO overestimated the numbers of female BRCA1/2 mutation carriers at thresholds ≥20% but underestimated if <20%. BRCAPRO and BOADICEA underestimated the number of male BRCA1/2 mutation carriers whilst Myriad II underestimated the number of both male and female carriers. In females, BRCAPRO showed similar discrimination, as measured by the area under the receiver operator characteristic curve (AUC) for BRCA1/2 combined mutation prediction to BOADICEA, but performed better than BOADICEA in BRCA1 mutation prediction (AUC 93% vs. 87%). BOADICEA had the best discrimination for BRCA1/2 combined mutation prediction (AUC 87%) in males.

Conclusions

The variation in model performance underscores the need for research on larger Asian cohorts as prediction models, and the possible need for customizing these models for different ethnic groups and genders.
Literature
1.
go back to reference Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130PubMedCrossRef Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130PubMedCrossRef
2.
go back to reference Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333PubMedCrossRef Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333PubMedCrossRef
3.
go back to reference Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694–1706PubMedCrossRef Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694–1706PubMedCrossRef
4.
go back to reference Pal T, Permuth-Wey J, Betts JA et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807–2816PubMedCrossRef Pal T, Permuth-Wey J, Betts JA et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807–2816PubMedCrossRef
5.
go back to reference Beristain E, Martinez-Bouzas C, Guerra I et al (2007) Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling. Breast Cancer Res Treat 106:255–262PubMedCrossRef Beristain E, Martinez-Bouzas C, Guerra I et al (2007) Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling. Breast Cancer Res Treat 106:255–262PubMedCrossRef
6.
go back to reference Martin AM, Blackwood MA, Antin-Ozerkis D et al (2001) Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J Clin Oncol 19:2247–2253PubMed Martin AM, Blackwood MA, Antin-Ozerkis D et al (2001) Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J Clin Oncol 19:2247–2253PubMed
7.
go back to reference Shah P, Robbani I, Shah O (2009) Clinicopathological study of male breast carcinoma: 24 years of experience. Ann Saudi Med 29:288–293PubMedCrossRef Shah P, Robbani I, Shah O (2009) Clinicopathological study of male breast carcinoma: 24 years of experience. Ann Saudi Med 29:288–293PubMedCrossRef
8.
go back to reference Ottini L, Rizzolo P, Zanna I et al (2009) BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. Breast Cancer Res Treat 116:577–586PubMedCrossRef Ottini L, Rizzolo P, Zanna I et al (2009) BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. Breast Cancer Res Treat 116:577–586PubMedCrossRef
9.
go back to reference Kash KM, Ortega-Verdejo K, Dabney MK et al (2000) Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer. Semin Surg Oncol 18:333–338PubMedCrossRef Kash KM, Ortega-Verdejo K, Dabney MK et al (2000) Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer. Semin Surg Oncol 18:333–338PubMedCrossRef
10.
go back to reference McInerney-Leo A, Biesecker BB, Hadley DW et al (2005) BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. Am J Med Genet A 133A:165–169PubMedCrossRef McInerney-Leo A, Biesecker BB, Hadley DW et al (2005) BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. Am J Med Genet A 133A:165–169PubMedCrossRef
11.
go back to reference Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490PubMedCrossRef Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490PubMedCrossRef
12.
go back to reference Antoniou AC, Pharoah PD, McMullan G et al (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86:76–83PubMedCrossRef Antoniou AC, Pharoah PD, McMullan G et al (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86:76–83PubMedCrossRef
13.
go back to reference Antoniou AC, Durocher F, Smith P et al (2006) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8:R3PubMedCrossRef Antoniou AC, Durocher F, Smith P et al (2006) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8:R3PubMedCrossRef
14.
go back to reference Berry DA, Parmigiani G, Sanchez J et al (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227–238PubMedCrossRef Berry DA, Parmigiani G, Sanchez J et al (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227–238PubMedCrossRef
15.
go back to reference Berry DA, Iversen ES Jr, Gudbjartsson DF et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701–2712PubMedCrossRef Berry DA, Iversen ES Jr, Gudbjartsson DF et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701–2712PubMedCrossRef
16.
go back to reference Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145–158PubMedCrossRef Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145–158PubMedCrossRef
17.
go back to reference Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409–1415PubMedCrossRef Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409–1415PubMedCrossRef
18.
go back to reference Shattuck-Eidens D, Oliphant A, McClure M et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278:1242–1250PubMedCrossRef Shattuck-Eidens D, Oliphant A, McClure M et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278:1242–1250PubMedCrossRef
19.
go back to reference Evans DG, Eccles DM, Rahman N et al (2004) A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41:474–480PubMedCrossRef Evans DG, Eccles DM, Rahman N et al (2004) A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41:474–480PubMedCrossRef
20.
go back to reference Weitzel JN, Lagos V, Blazer KR et al (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14:1666–1671PubMedCrossRef Weitzel JN, Lagos V, Blazer KR et al (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14:1666–1671PubMedCrossRef
21.
go back to reference Nanda R, Schumm LP, Cummings S et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925–1933PubMedCrossRef Nanda R, Schumm LP, Cummings S et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925–1933PubMedCrossRef
22.
go back to reference Vogel KJ, Atchley DP, Erlichman J et al (2007) BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol 25:4635–4641PubMedCrossRef Vogel KJ, Atchley DP, Erlichman J et al (2007) BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol 25:4635–4641PubMedCrossRef
23.
go back to reference Kurian AW, Gong GD, John EM et al (2009) Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 18:1084–1091PubMedCrossRef Kurian AW, Gong GD, John EM et al (2009) Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 18:1084–1091PubMedCrossRef
25.
go back to reference Kwong A, Wong LP, Chan KY et al (2008) Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family. Fam Cancer 7:125–133PubMedCrossRef Kwong A, Wong LP, Chan KY et al (2008) Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family. Fam Cancer 7:125–133PubMedCrossRef
26.
go back to reference Hu Z, Li WF, Liu XY et al (2008) BRCA1/2 gene mutation in Chinese familial breast cancer patients: a multi-center report of 115 cases. Zhonghua Yi Xue Za Zhi 88:2383–2386PubMed Hu Z, Li WF, Liu XY et al (2008) BRCA1/2 gene mutation in Chinese familial breast cancer patients: a multi-center report of 115 cases. Zhonghua Yi Xue Za Zhi 88:2383–2386PubMed
27.
go back to reference Han SH, Lee KR, Lee DG et al (2006) Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet 70:496–501PubMedCrossRef Han SH, Lee KR, Lee DG et al (2006) Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet 70:496–501PubMedCrossRef
28.
go back to reference Li WF, Hu Z, Rao NY et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110:99–109PubMedCrossRef Li WF, Hu Z, Rao NY et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110:99–109PubMedCrossRef
29.
go back to reference Kwong A, Wong LP, Wong HN et al (2009) Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J 3:63–76PubMedCrossRef Kwong A, Wong LP, Wong HN et al (2009) Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J 3:63–76PubMedCrossRef
30.
go back to reference Ikeda N, Miyoshi Y, Yoneda K et al (2001) Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83–88PubMedCrossRef Ikeda N, Miyoshi Y, Yoneda K et al (2001) Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83–88PubMedCrossRef
31.
go back to reference Thirthagiri E, Lee S, Kang P et al (2008) Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res 10:R59PubMedCrossRef Thirthagiri E, Lee S, Kang P et al (2008) Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res 10:R59PubMedCrossRef
32.
go back to reference Rao NY, Hu Z, Li WF et al (2009) Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 113:467–477PubMedCrossRef Rao NY, Hu Z, Li WF et al (2009) Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 113:467–477PubMedCrossRef
33.
go back to reference Kurian AW, Gong GD, Chun NM et al (2008) Performance of BRCA1/2 Mutation Prediction Models in Asian Americans. J Clin Oncol 26(29):4752–4758PubMedCrossRef Kurian AW, Gong GD, Chun NM et al (2008) Performance of BRCA1/2 Mutation Prediction Models in Asian Americans. J Clin Oncol 26(29):4752–4758PubMedCrossRef
34.
go back to reference Rao NY, Hu Z, Yu JM et al (2008) Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients. Breast Cancer Res Treat 116:563–570PubMedCrossRef Rao NY, Hu Z, Yu JM et al (2008) Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients. Breast Cancer Res Treat 116:563–570PubMedCrossRef
35.
go back to reference Panchal SM, Ennis M, Canon S, Bordeleau LJ (2008) Selecting a BRCA risk assessment model for use in a familial cancer clinic. BMC Med Genet 9:116PubMedCrossRef Panchal SM, Ennis M, Canon S, Bordeleau LJ (2008) Selecting a BRCA risk assessment model for use in a familial cancer clinic. BMC Med Genet 9:116PubMedCrossRef
36.
go back to reference Kwong A, Wong LP, Wong HN et al (2009) A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 117:683–686PubMedCrossRef Kwong A, Wong LP, Wong HN et al (2009) A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 117:683–686PubMedCrossRef
37.
go back to reference Weitzel JN, Lagos VI, Cullinane CA et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297:2587–2595PubMedCrossRef Weitzel JN, Lagos VI, Cullinane CA et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297:2587–2595PubMedCrossRef
38.
go back to reference Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301–1308CrossRef Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301–1308CrossRef
39.
go back to reference Peto J, Collins N, Barfoot R et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–949PubMedCrossRef Peto J, Collins N, Barfoot R et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–949PubMedCrossRef
40.
go back to reference Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222–2233PubMedCrossRef Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222–2233PubMedCrossRef
41.
go back to reference Hou MF, Tsai KB, Fan HM et al (2000) Familial breast cancer in southern Taiwan. Kaohsiung J Med Sci 16:414–421PubMed Hou MF, Tsai KB, Fan HM et al (2000) Familial breast cancer in southern Taiwan. Kaohsiung J Med Sci 16:414–421PubMed
42.
go back to reference Ahn SH, Son BH, Yoon KS et al (2007) BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 245:90–95PubMedCrossRef Ahn SH, Son BH, Yoon KS et al (2007) BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 245:90–95PubMedCrossRef
43.
go back to reference Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66:8297–8308PubMedCrossRef Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66:8297–8308PubMedCrossRef
44.
go back to reference Johannesdottir G, Gudmundsson J, Bergthorsson JT et al (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56:3663–3665PubMed Johannesdottir G, Gudmundsson J, Bergthorsson JT et al (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56:3663–3665PubMed
45.
go back to reference John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869–2876PubMedCrossRef John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869–2876PubMedCrossRef
46.
go back to reference Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413–424PubMedCrossRef Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413–424PubMedCrossRef
47.
go back to reference Euhus DM, Smith KC, Robinson L et al (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:844–851PubMedCrossRef Euhus DM, Smith KC, Robinson L et al (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:844–851PubMedCrossRef
48.
go back to reference Marroni F, Aretini P, D’Andrea E et al (2004) Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet 41:278–285PubMedCrossRef Marroni F, Aretini P, D’Andrea E et al (2004) Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet 41:278–285PubMedCrossRef
49.
go back to reference Antoniou AC, Hardy R, Walker L et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 45:425–431PubMedCrossRef Antoniou AC, Hardy R, Walker L et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 45:425–431PubMedCrossRef
50.
go back to reference Katki HA (2006) Effect of misreported family history on Mendelian mutation prediction models. Biometrics 62:478–487PubMedCrossRef Katki HA (2006) Effect of misreported family history on Mendelian mutation prediction models. Biometrics 62:478–487PubMedCrossRef
51.
go back to reference Barlow-Stewart K, Yeo SS, Meiser B et al (2006) Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genet Med 8:24–32PubMedCrossRef Barlow-Stewart K, Yeo SS, Meiser B et al (2006) Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genet Med 8:24–32PubMedCrossRef
52.
go back to reference Zanna I, Rizzolo P, Sera F et al (2010) The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases. Eur J Hum Genet 18:856–858PubMedCrossRef Zanna I, Rizzolo P, Sera F et al (2010) The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases. Eur J Hum Genet 18:856–858PubMedCrossRef
53.
go back to reference Huo D, Senie RT, Daly M et al (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United States. J Clin Oncol 27:1184–1190PubMedCrossRef Huo D, Senie RT, Daly M et al (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United States. J Clin Oncol 27:1184–1190PubMedCrossRef
54.
go back to reference Mavaddat N, Rebbeck TR, Lakhani SR et al (2010) Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res 12:R28PubMedCrossRef Mavaddat N, Rebbeck TR, Lakhani SR et al (2010) Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res 12:R28PubMedCrossRef
56.
go back to reference Katki HA (2007) Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet 8:13PubMedCrossRef Katki HA (2007) Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet 8:13PubMedCrossRef
Metadata
Title
Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in a Southern Chinese Cohort
Authors
Ava Kwong
Connie H. N. Wong
Dacita T. K. Suen
Michael Co
Allison W. Kurian
Dee W. West
James M. Ford
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 4/2012
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1406-y

Other articles of this Issue 4/2012

World Journal of Surgery 4/2012 Go to the issue